Rabinovitch, Marlene
Stanford Medicine · Stanford Cardiovascular Institute · Stanford University
8 papers on CoChatORCID 0000-0001-7886-7104
Most cited papers
- Verified
Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome
Nakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology
Inflammasome and immune disordersAutophagy in Disease and Therapy
Cited by 3,049
- Verified
Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension
Rabinovitch, M., Guignabert, C., Humbert, M., & Nicolls, M. R. (2014) · Circulation Research
Pulmonary Hypertension Research and TreatmentsCardiac Fibrosis and Remodeling
Cited by 1,029
- Verified
An antiproliferative BMP-2/PPARγ/apoE axis in human and murine SMCs and its role in pulmonary hypertension
Hansmann, G., de Jesus Perez, V. A., Alastalo, T.-P., Alvira, C. M., Guignabert, C., Bekker, J. M., Schellong, S., Urashima, T., Wang, L., Morrell, N. W., et al. (2008) · Journal of Clinical Investigation
Pulmonary Hypertension Research and TreatmentsTGF-β signaling in diseases
Cited by 367
- Verified
Autophagic protein LC3B confers resistance against hypoxia-induced pulmonary hypertension.
Lee, S.-J., Smith, A., Guo, L., Alastalo, T.-P., Li, M., Sawada, H., Liu, X., Chen, Z.-H., Ifedigbo, E., Jin, Y., et al. (2011) · American Journal of Respiratory and Critical Care Medicine
Pulmonary Hypertension Research and TreatmentsAutophagy in Disease and Therapy
Cited by 217
- Verified
Cellular senescence impairs the reversibility of pulmonary arterial hypertension
van der Feen, D. E., Bossers, G. P. L., Hagdorn, Q. A. J., Moonen, J.-R., Kurakula, K., Szulcek, R., Chappell, J., Vallania, F., Donato, M., Kok, K., et al. (2020) · Science Translational Medicine
Pulmonary Hypertension Research and TreatmentsTelomeres, Telomerase, and Senescence
Cited by 150
- Verified
Clinical trial in a dish using iPSCs shows lovastatin improves endothelial dysfunction and cellular cross-talk in LMNA cardiomyopathy
Sayed, N., Liu, C., Ameen, M., Himmati, F., Zhang, J. Z., Khanamiri, S., Moonen, J.-R., Wnorowski, A., Cheng, L., Rhee, J.-W., et al. (2020) · Science Translational Medicine
Pluripotent Stem Cells ResearchCardiomyopathy and Myosin Studies
Cited by 111
- Verified
Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis
Opavsky, M. A., Martino, T., Rabinovitch, M., Penninger, J., Richardson, C., Petric, M., Trinidad, C., Butcher, L., Chan, J., & Liu, P. P. (2002) · Journal of Clinical Investigation
Viral Infections and Immunology ResearchCardiac Fibrosis and Remodeling
Cited by 91
- Verified
Developmental expression of LC3α and β: Absence of fibronectin or autophagy phenotype in LC3β knockout mice
Cann, G. M., Guignabert, C., Ying, L., Deshpande, N., Bekker, J. M., Wang, L., Zhou, B., & Rabinovitch, M. (2008) · Developmental Dynamics
Autophagy in Disease and TherapyDevelopmental Biology and Gene Regulation
Cited by 84
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free